In our study, we also used IHC analysis to evaluate TOP2A overexpression as a significant prognostic factor in luminal breast cancer; however, the prognostic value was restricted in luminal B breast cancer, defined as tumors with high Ki67 index and/or low PgR expression. This evidence concerns the gene TOP2A and breast carcinoma.